• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALLI JUGULAR SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALLI JUGULAR SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900J
Device Problem Occlusion Within Device (1423)
Patient Problem Thrombus (2101)
Event Date 05/24/2014
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only event reported to date for this lot number and failure mode.Medical records review: the patient with history of ulcerative colitis and deep vein thrombosis had a retrievable inferior vena cava (ivc) filter deployed in the infrarenal ivc.Approximately four days post filter deployment, the patient was admitted to the hospital with complaint of leg pain.A diagnostic venogram was performed which demonstrated nonocclusive thrombus throughout the right thigh with occlusive thrombus in the right common femoral vein and iliac vein as well as the ivc.There was an extension of thrombus beyond the filter for approximately 4 cm but the thrombus appeared to be below the renal veins with patency of the ivc above the renal veins.Mechanical thrombolysis and pharmacomechanical thrombolysis were performed.Completion venogram demonstrated a thrombosed common iliac vein and ivc.An infusion catheter was place and a thrombolytic infusion was initiated.Approximately ten hours post tpa infusion, venogram demonstrated clearing of the thrombus within the common iliac and in the ivc with the exception of occlusive thrombus directly at the level of the filter.Following an embolectomy procedure, a venogram demonstrated persistent occlusion of the filter with thrombus in it.Therefore, a 4mm x 10 cm balloon was placed at two separate locations through two separate struts of the filter, and several passes were made with suction which removed fibrin and thrombus.Final venogram demonstrated a manageable amount of thrombus within the filter with no thrombus above the filter and flow re-establishment.Approximately one year one months post filter deployment, ct of the abdomen and pelvis demonstrated no evidence of ivc filter thrombosis.Investigation summary: the device was not returned for evaluation.Images were not provided for review.Medical records were provided and reviewed.Based on the medical records, the investigation can be confirmed for occlusion of the filter as well as thrombus above the filter.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.Expiry date: 03/2017; 03/2014.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, occlusion was identified.The filter was not removed and there were no reported filter retrieval attempts performed.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALLI JUGULAR SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key7528130
MDR Text Key108721273
Report Number2020394-2018-00695
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040795
UDI-Public(01)00801741040795
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Attorney
Type of Report Initial
Report Date 05/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDL900J
Device Catalogue NumberDL900J
Device Lot NumberGFYB3276
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age48 YR
Patient Weight79
-
-